{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:44:56Z","timestamp":1762271096060},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.cancergencyto.2006.09.015","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T12:04:02Z","timestamp":1168257842000},"page":"107-112","source":"Crossref","is-referenced-by-count":11,"title":["A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis"],"prefix":"10.1016","volume":"172","author":[{"given":"Thomas Stauffer","family":"Larsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Carl","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Pallisgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte Birk","family":"Kerndrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2006.09.015_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2141.2005.05413.x","article-title":"Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study","volume":"129","author":"Al-Assar","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib6","first-page":"224","article-title":"Karyotype and molecular cytogenetic studies in polycythemia vera","volume":"4","author":"Andrieux","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0025-6196(12)61011-8","article-title":"Chromosome studies in 104 patients with polycythemia vera","volume":"66","author":"ez-Martin","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.seminoncol.2005.04.007","article-title":"Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia","volume":"32","author":"Reilly","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V72.2.386.386","article-title":"A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course","volume":"72","author":"Swolin","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2141.1997.1722990.x","article-title":"Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases","volume":"98","author":"Reilly","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-4608(02)00678-7","article-title":"Karyotypic abnormalities in myelofibrosis following polycythemia vera","volume":"140","author":"Andrieux","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cancergencyto.2004.12.015","article-title":"Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders","volume":"160","author":"Bacher","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X","article-title":"Gain of 9p in the pathogenesis of polycythemia vera","volume":"22","author":"Chen","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.1979.tb03739.x","article-title":"Transitional myeloproliferative disorder","volume":"43","author":"Pettit","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib15","doi-asserted-by":"crossref","unstructured":"Pedersen RK, Kerndrup GB, Sorensen AG, Mourits-Andersen T, Gram-Hansen P, Pulczynski S, Schmidt KG. Cytogenetic aberrations in adult acute lymphocytic leukemia: optimal technique may influence the results. Cancer Genet Cytogenet;128:7\u201310.","DOI":"10.1016\/S0165-4608(01)00388-0"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(99)00223-X","article-title":"Acute leukemia cytogenetics: an evaluation of combining G-band karyotyping with multi-color spectral karyotyping","volume":"124","author":"Kerndrup","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib17","article-title":"The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD","volume":"1","author":"Vardiman","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib18","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.21645","article-title":"The clinical phenotype of wild-type, heterozygous, and homozygous JAK2(V617F) in polycythemia vera","volume":"106","author":"Tefferi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.humpath.2005.07.020","article-title":"Myelodysplastic\/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case","volume":"36","author":"Heiss","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergencyto.2006.09.015_bib21","doi-asserted-by":"crossref","unstructured":"Bousquet M, Quelen C, De M, V, Duchayne E, Roquefeuil B, Delsol G, Laurent G, Dastugue N, Brousset P. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene 2005;24:7248\u201352.","DOI":"10.1038\/sj.onc.1208850"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806006170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806006170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:06:29Z","timestamp":1587315989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460806006170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0165460806006170"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.09.015","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}